• Etomoxir in Immunometabolism: Protocol Optimization & Transl

  2026-07-17

  Explore how Etomoxir, a potent CPT-1 inhibitor, advances fatty acid oxidation pathway research and immunometabolic assay design. This article reveals protocol innovations and translational considerations missed by standard guides.

• Glucocorticoids Rapidly Modulate Kv2.1 and CaV1.2 in Hippoca

  2026-07-17

  This study uncovers a rapid, nongenomic mechanism by which glucocorticoids suppress CaV1.2-mediated calcium signals in hippocampal neurons via promoting Kv2.1 channel endocytosis and reducing PKA activity. These findings clarify how stress hormones swiftly modulate neuronal excitability, with implications for understanding neuroendocrine regulation in the brain.

• Sodium Picosulfate in Gut–Liver–Brain Axis Models: Mechanist

  2026-07-16

  Explore the advanced mechanistic roles and optimized research protocols for Sodium Picosulfate in gut–liver–brain axis studies. This article uniquely bridges detailed molecular action with workflow design, setting it apart from existing resources.

• CmOGD2 Regulation Enables Ferroptosis-Mediated Citrus Canker

  2026-07-16

  This study reveals how CmOGD2, a 2-oxoglutarate-dependent dioxygenase, mediates resistance to citrus canker in Citron by enhancing iron uptake and triggering ROS-dependent ferroptosis. The findings uncover a complex regulatory network involving pathogen effectors and metabolic feedback, with broad implications for plant-pathogen interaction and redox signaling research.

• IPA Pathway-Mediated Auxin Biosynthesis in Neurospora crassa

  2026-07-15

  This study provides the first genetic and biochemical evidence for the indole-3-pyruvic acid (IPA) pathway of indole-3-acetic acid (IAA) biosynthesis in the non-pathogenic fungus Neurospora crassa. The findings illuminate conserved auxin biosynthesis mechanisms across kingdoms and open new directions for plant hormone research and fungal biotechnology.

• Lipid Scrambling in Ferroptosis: TMEM16F as a Tumor Immune T

  2026-07-15

  Yang et al. identify TMEM16F-mediated lipid scrambling as a pivotal suppressor of ferroptosis, demonstrating that its inhibition sensitizes tumor cells to ferroptotic death and enhances tumor immune rejection. These findings clarify late-stage ferroptosis mechanisms and propose new strategies for cancer immunotherapy by targeting plasma membrane lipid remodeling.

• Bay 11-7085: Precision NF-κB Activation Inhibitor for Advanc

  2026-07-14

  Bay 11-7085 is a benchmark NF-κB activation inhibitor, enabling high-specificity dissection of inflammation and apoptosis pathways. Its robust performance in cell-based and animal models makes it indispensable for translational research, especially in complex neuroinflammatory and endometriosis workflows.

• Biosynthetic Pathway Manipulation of the Dalbavancin Precurs

  2026-07-14

  This review dissects the molecular and genetic innovations enabling production and diversification of A40926, a natural glycopeptide and dalbavancin precursor. The reference paper details the elucidation and targeted engineering of its biosynthetic gene cluster in Nonomuraea, enabling new derivative generation and advancing glycopeptide antibiotic research.

• PD 173074 in Cancer Research: Optimizing FGFR/VEGFR2 Inhibit

  2026-07-13

  PD 173074 offers unrivaled selectivity for FGFR1 and VEGFR2, empowering researchers to dissect angiogenesis and tumor progression with nanomolar precision. This guide delivers actionable workflows, troubleshooting insights, and evidence-driven protocol enhancements for translational and preclinical studies.

• Regulatory Enhancement of A40926 Production in Nonomuraea sp

  2026-07-13

  This study introduces new molecular tools to precisely regulate and enhance the biosynthesis of A40926, the natural glycopeptide precursor of dalbavancin, in Nonomuraea gerenzanensis. By deploying engineered promoters and targeted overexpression of pathway-specific regulatory genes, the authors demonstrate significant improvements in fermentation yields, providing a foundation for advanced antibiotic development and production.

• 4-Methylumbelliferyl-β-D-Glucopyranoside in Lysosomal Enzyme

  2026-07-12

  4-Methylumbelliferyl-β-D-Glucopyranoside (4-MUG) enables precise, high-sensitivity quantification of β-glucosidase and β-glucocerebrosidase activity, powering translational research in lysosomal storage disorders. This guide explores advanced workflows, hands-on troubleshooting, and practical protocol enhancements to maximize 4-MUG assay performance in both bench research and therapeutic development.

• Poly(I:C): Synthetic Double-Stranded RNA Analog for Immune M

  2026-07-10

  Poly(I:C) stands out as a gold-standard synthetic double-stranded RNA analog for robust TLR3 activation and dendritic cell maturation. This guide translates cutting-edge findings into high-performance workflows, troubleshooting strategies, and actionable protocol enhancements for immunology, antiviral screening, and cross-domain research.

• Palonosetron Hydrochloride in Chemotherapy-Induced Nausea Co

  2026-07-09

  Ruhlmann and Herrstedt's study provides a detailed evaluation of palonosetron hydrochloride as an advanced 5-HT3 receptor antagonist for chemotherapy-induced nausea and vomiting (CINV). Their analysis highlights the drug's pharmacological distinctions, clinical effectiveness, and implications for antiemetic regimen optimization in oncology research.

• Bacterial OMV-Based mRNA Display for Personalized Tumor Vacc

  2026-07-09

  This study introduces a novel mRNA vaccine delivery platform using genetically engineered bacterial outer membrane vesicles (OMVs) to rapidly display and deliver antigen-encoding mRNA for personalized cancer immunotherapy. The approach demonstrates potent antitumor effects and long-term immune protection, offering a promising alternative to lipid nanoparticle-based mRNA vaccines.

• Trelagliptin Succinate: Beyond Diabetes—New Mechanistic Insi

  2026-07-08

  Explore how Trelagliptin succinate, a selective DPP-4 inhibitor, advances type 2 diabetes research and reveals novel osteogenic mechanisms. This article uniquely analyzes AMPK–RUNX2 signaling, practical protocols, and translational value for metabolic and bone biology studies.

466 records 12/32 page Previous Next First page 上5页 1112131415 下5页 Last page